# Safety and Preliminary Efficacy of Lipoxin Analog BLXA4-ME Oral Rinse for the Treatment of Gingivitis

> **NCT02342691** · PHASE1,PHASE2 · COMPLETED · sponsor: **The Forsyth Institute** · enrollment: 127 (actual)

## Conditions studied

- Gingival Inflammation

## Interventions

- **DRUG:** BLXA4
- **DRUG:** Placebo oral rinse

## Key facts

- **NCT ID:** NCT02342691
- **Lead sponsor:** The Forsyth Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2017-09-28
- **Final completion:** 2019-08-30
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2023-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02342691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02342691, "Safety and Preliminary Efficacy of Lipoxin Analog BLXA4-ME Oral Rinse for the Treatment of Gingivitis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02342691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*